Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous lidocaine on the ED50 of ciprofol for suppressing gastroscope insertion reaction
ChiCTR2300075224Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Aug 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in procedural pain (2 arms), sponsored by Jiaxing Second Hospital. Primary endpoint: Median effective dose (ED50) of ciprofol. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2300075224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075224.